Owens & Minor/$OMI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Owens & Minor

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Ticker

$OMI

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

23,200

ISIN

US6907321029

Owens & Minor Metrics

BasicAdvanced
$680M
-
-$4.75
1.31
-

What the Analysts think about Owens & Minor

Analyst ratings (Buy, Hold, Sell) for Owens & Minor stock.

Bulls say / Bears say

Owens & Minor's Patient Direct segment achieved mid-single-digit growth in Q1 2025, contributing to a mid-teen expansion in EBITDA, indicating strong performance in direct-to-patient services. (TipRanks)
The company reduced its total debt by over $240 million in 2024, demonstrating a commitment to strengthening its balance sheet and reducing financial leverage. (Market Inference)
Owens & Minor's Q2 2024 revenue of $2.67 billion surpassed analyst estimates, reflecting effective execution of its growth strategy. (GuruFocus)
The company reported a GAAP net loss of $31.9 million in Q2 2024, translating to a loss per share of $0.42, which is higher than the estimated loss per share of $0.17. (GuruFocus)
Owens & Minor recorded a non-cash goodwill impairment charge of approximately $310 million in its Apria division, indicating potential overvaluation of acquired assets. (Market Inference)
The company reported a net loss of $25 million in Q1 2025, slightly higher than the previous year's loss, suggesting ongoing profitability challenges. (TipRanks)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

Owens & Minor Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Owens & Minor Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OMI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs